Skip to main content

Table 1 Comparison of clinical characteristics and MRI features between patients with Ki-67 low expression and those with high expression of HNSCC

From: Prediction of the Ki-67 expression level in head and neck squamous cell carcinoma with machine learning-based multiparametric MRI radiomics: a multicenter study

Characteristic

Training cohort (n = 196)

P value

Internal Validation cohort (n = 84)

P value

External Validation cohort (n = 71)

P value

Low Ki-67 expression (n = 104)

High Ki-67 expression (n = 92)

Low Ki-67 expression (n = 44)

High Ki-67 expression (n = 40)

Low Ki-67 expression (n = 38)

High Ki-67 expression (n = 33)

Age, years

  

0.495

  

0.785

  

0.702

 < 60

48 (46.1)

38 (41.3)

 

20 (45.5)

17 (42.5)

 

19 (50.0)

15 (45.5)

 

 ≥ 60

56 (53.8)

54 (58.7)

 

24 (54.5)

23 (57.5)

 

19 (50.0)

18 (54.5)

 

Sex

  

0.187

  

0.403

  

0.571

Male

85 (81.7)

68 (73.9)

 

33 (75.0)

33 (82.5)

 

29 (76.3)

27 (81.8)

 

Female

19 (18.3)

24 (26.1)

 

11 (25.0)

7 (17.5)

 

9 (23.7)

6 (18.2)

 

Smoking history

  

0.767

  

0.749

  

0.592

No

60 (57.7)

55 (59.8)

 

26 (59.1)

25 (62.5)

 

23 (60.5)

22 (66.7)

 

Yes

44 (42.3)

37 (40.2)

 

18 (40.9)

15 (37.5)

 

15 (39.5)

11 (33.3)

 

Tumor location

  

0.466

  

0.226

  

0.113

Oral cavity

42 (40.4)

33 (35.9)

 

20 (45.4)

13 (32.5)

 

18 (47.4)

10 (30.3)

 

Oropharynx

11 (10.6)

17 (18.5)

 

7 (15.9)

4 (10.0)

 

6 (15.8)

3 (9.1)

 

Larynx

35 (33.6)

28 (30.4)

 

15 (34.1)

17 (42.5)

 

12 (31.6)

13 (39.4)

 

Hypopharynx

16 (15.4)

14 (15.2)

 

2 (4.5)

6 (15.0)

 

2 (5.3)

7 (21.2)

 

Clinical T stage

  

 < 0.001

  

0.004

  

0.006

T1-T2

63 (60.6)

24 (26.1)

 

28 (63.6)

13 (32.5)

 

24 (63.2)

10 (30.3)

 

T3-T4

41 (39.4)

68 (73.9)

 

16 (36.4)

27 (67.5)

 

14 (36.8)

23 (69.7)

 

MR-reported LN status

  

 < 0.001

  

0.005

  

0.029

Negative

78 (75.0)

42 (45.7)

 

33 (75.0)

18 (45.0)

 

27 (71.1)

15 (45.5)

 

Positive

26 (25.0)

50 (54.3)

 

11 (25.0)

22 (55.0)

 

11 (28.9)

18 (54.5)

 
  1. HNSCC Head and neck squamous cell carcinoma, LN Lymph node, MRI Magnetic resonance imaging